stephan toutain  interleukin genetics  inc  zoominfocom stephan toutain  biotech consultant llc  zoominfocom stephan f toutain  la grange il  intelius sign in we found stephan f toutain in la grange il stephan f toutain intelius found that stephan f toutain from la grange il we have connected them to  addresses  phone and  relatives or associates get report now stephan has lived in la grange il summit nj randolph nj stephans relatives lesley toutain winston toutain stephan f toutain professional status celgene corporation get report now want to know more about stephan get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about stephan or use our people search engine to find others get background check on stephan f toutain get a criminal check on stephan f toutain get a public record report on stephan f toutain get a people search report on stephan f toutain stephan f toutains contact information known cities lived in find out where stephan f toutain has lived as well as stephan f toutains phone numbers and email addresses stephan f toutain has lived in  states illinois address for stephan f toutain   s la grange il has lived in la grange il summit nj get full address report phone numbers associated with stephan f toutain   get full phone report email addresses associated with stephan f toutain get email report stephan f toutains professional information information regarding stephan f toutains professional history find out previous places stephan f toutain has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act stephan f toutain has worked at  place company celgene corporation stephan f toutains experience title company celgene corporation job details celgene corporation is an integrated biopharmaceutical company the company is primarily engaged in the discovery development and commercialization of therapies designed to treat cancer and immuneinflammatory related diseases it is involved in research in several scientific areas that may deliver therapies targeting areas such as intracellular signaling pathways in cancer and immune cells immunomodulation in cancer and autoimmunity and placental cell including stem and progenitor cell research the drug and cell therapies it develops are designed to treat lifethreatening diseases or chronic debilitating conditions the company’s commercial stage products include revlimid thalomid inclusive of thalidomide pharmion vidaza alkeran and focalin on march   it acquired pharmion corporation a biopharmaceutical company that acquired developed and commercialized products for the treatment of hematology and oncology patientssource k additional professional information on stephan f toutain see stephan f toutains linkedin profile stephan f toutains social network and potential email matches find out potential social network profiles and potential email usernamed for stephan f toutain stephan f toutains known social networks and potential email matches find all of stephan f toutains social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches stephan toutain username matches stephantoutain toutainstephan stephantoutain toutainstephan stephantoutain toutainstephan stephantoutain toutainstephan stoutain popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches s toutain intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here stephan toutain interleukin genetics inc profile  biography  bloomberg feedback stephan toutain chief commercial officer interleukin genetics inc career history chief commercial officer interleukin genetics inc 6present headglobal commercial dev sarepta therapeutics inc former website wwwilgeneticscom corporate information address  beaver street waltham ma  united states phone  fax  web url wwwilgeneticscom from the web personal information education university of north carolina system mba university de nancy  iae masters degree engineering sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data stephan toutain  chief commercial officer at interleukin genetics inc news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink stephan toutain chief commercial officer at interleukin genetics inc overview in the news relationships paths education career history stephan toutain chief commercial officer at interleukin genetics inc overview number of relationships this person is connected to  people in the news see more globenewswire november  6 interleukin genetics reports third quarter 6 financial results globenewswire august 6 6 interleukin genetics reports second quarter 6 financial results globenewswire august  6 interleukin genetics strengthens commercial leadership with key appointments relationships see details kenneth s kornman editorinchief journal of periodontology at american academy of periodontology mark b carbeau former chief executive officer at interleukin genetics inc stephen dipalma chief financial officer at cognition therapeutics inc mary hiter marketing director at interleukin genetics inc paula a cloghessy vice president human resources at joule unlimited technologies inc eliot lurier chief operating officer  chief financial officer at joslin diabetes center at the harvard stem cell institute nazneen aziz president  chief scientific officer at vitrimark inc barry kallander director president secretary  treasurer at interleukin genetics inc philip r reilly former venture partner at third rock ventures llc lewis h bender founder  chief executive officer at intensity therapeutics inc see  more listings with relsci professional start my free trial ➤ see  more paths to stephan toutain stephan toutain you connections via relationship science stephan toutain sync your contacts to see how you can connect with stephan toutain start my free trial ➤ see more educational background   the university of north carolina at chapel hill the university of north carolina at chapel hill also known as unc uncchapel hill chapel hill north carolina or simply carolina is a coeducational public research university located in chapel hill north carolina united states north carolina has been consistently ranked among the highest ranked universities in the united states and is one of the original eight public ivy schools that provide an ivy league experience for a public schooling price after being chartered in  the university first began enrolling students in  which allows it to be one of three schools to claim the title of the oldest public university in the united states   nancyuniversité career history chief commercial officer 6  current interleukin genetics inc interleukin genetics inc is a molecular diagnostics company which develops and commercializes genetic tests to guide better prevention and treatment of chronic diseases of aging its products include priopredict genetic risk test and inherent health the company was founded by kenneth s kornman in 6 and is headquartered in waltham ma other affiliations stephan toutain is affiliated with interleukin genetics inc youve reached your  free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ stephan toutain   boston business journal menu select a city national albany albuquerque atlanta austin baltimore birmingham boston buffalo charlotte chicago cincinnati columbus dallas dayton denver greensborowinstonsalem honolulu houston jacksonville kansas city los angeles louisville memphis miamifort lauderdale milwaukee minneapolisst paul nashville new york orlando philadelphia phoenix pittsburgh portland raleighdurham sacramento san antonio san francisco seattle silicon valley st louis tampa bay washington dc wichita limited time offer subscribe now search × close sign in sign in your account your account welcome your account sign in existing users create your free account dont have an account your account subscriptions newsletters custom notifications my custom site manage site users sign out sign in sign in your account search home industries  topics all industries  topics banking  financial services career  workplace commercial real estate education energy food  lifestyle government  regulations health care manufacturing media  marketing philanthropy  nonprofits professional services residential real estate retailing sports business technology transportation travel  tourism sponsored content cre now energy solutions for business we value your business office environments small business marketing know your neighborhood news news latest news business pulse press releases subscribers subscriberonly content digital edition start a subscription sign up for newsletters lists  awards lists all lists access the book of lists purchase the book of lists build your own lists submit your company to be on a list awards nominate for an award people  companies companies top private companies find businesses for sale search for company news people people on the move contact top executives executive profiles search for people in the news events events business event calendar nominations add your event event photos signature events bizwomen mentoring monday more… jobs find or post a job in boston store subscriptions reprints  more sales leads public records information to build your business how to grow your business advance your career home of the day premium real estate listings in boston bizspace best office spaces available in boston thought leadership trends tips and insights from our partners bioflash newsletter real estate inc newsletter startups newsletter techflash newsletter five things to know startups  venture capital subscribers start a subscription subscriberonly content digital edition access the book of lists purchase the book of lists manage your account about  contact about us about the business journals advertise help  faqs contact us call center directory apps  syndication newsletters mobile apps syndicationrss acbj publications bizwomen upstart hemmings sports business journal inside lacrosse bostinno dcinno chicagoinno austininno select a city national albany albuquerque atlanta austin baltimore birmingham boston buffalo charlotte chicago cincinnati columbus dallas dayton denver greensborowinstonsalem honolulu houston jacksonville kansas city los angeles louisville memphis miamifort lauderdale milwaukee minneapolisst paul nashville new york orlando philadelphia phoenix pittsburgh portland raleighdurham sacramento san antonio san francisco seattle silicon valley st louis tampa bay washington dc wichita follow us twitter linkedin facebook google  sponsored by people on the move email facebook linkedin twitter print  of  img datasrchttpsmediabizjusviewimgstephantoutain66xxjpg srchttpsmediabizjusviewimgstephantoutain66xxjpg altstephan toutain new hire health care august  6 stephan toutain chief commercial officer at interleukin genetics education  university of north carolina at chapel hill nc stephan toutain joins interleukin genetics as the chief commercial officer in that role he will take the lead on accelerating commercial strategy by implementing commercial development providing market access as well as sales and marketing leadership  download contact information download sample vcard file more people on the move ltimg srchttpsmediabizjusviewimgtimothybbrownmdphd666xx6jpg alttimothy b brown md phdgt health care timothy b brown md phd mount auburn hospital ltimg srchttpsmediabizjusviewimg6drmonerawong666xx6jpg altdr monera wonggt health care dr monera wong atrius health ltimg srchttpsmediabizjusviewimg6binuphillipsmd666xxjpg altbinu phillips mdgt health care binu phillips md mount auburn hospital ltimg srchttpsmediabizjusviewimgmaryhiter666xxjpg altmary hitergt health care mary hiter interleukin genetics see more people on the move promote employees and keep your companys name in the news for  submit people on the move sign up for newsletters  alerts receive boston business journals morning edition and afternoon edition newsletters and breaking news alerts sign up next person on the move img srchttpsmediabizjusviewimg66mikelosier6xxjpg altmike losier commercial real estate mike losier cw services special offer subscribe now to search our database of  boston business journal people on the move submissions and download their contact information subscribe to download contacts people around the country img srchttpsmediabizjusviewimg6michaelifraimov66xx6png altmichael ifraimov michael ifraimov weatherford partners img srchttpsmediabizjusviewimg6michaeldworkin666xxjpg altmichael dworkin michael dworkin michael l dworkin and associates img srchttpsmediabizjusviewimgthadrwilsonxxjpg altthad r wilson phd thad r wilson phd research college of nursing see all people on the move featured jobs maitland fl national sales director activengage inc buffalo ny intellectual property attorney bond schoeneck  king pllc navarre fl clinic manager  davita kidney care davita inc buffalo ny estates wills  trusts attorney lipsitz green scime cambria llp washington dc director of business development home builders institute post a job see all jobs stephan toutain  ctsnet skip to main content ctsnet the cardiothoracic surgery network aboutparticipationstrategic plansponsorssponsorshipdisclaimerprivacy policycomment policycontact ussubmiteventsevents listingevents calendarsubmit an eventabstract deadlinesjansappslog inregister an account ctsnet is sponsored in part by an educational grant from homevideoscardiaccongenitalthoracicvascularroundtable videosgiants of cardiothoracic surgerypioneers in cardiac surgeryinnovatorstechniquescardiaccongenitalthoracicimage galleryportalscardiaccongenitalthoracicvascularallied healthaorticmeeting presentationssurgical volunteerismjournalsjournalsctsnet journal and news scanbookscareersus career centereuropean career centerprofilessurgeonsassociatesorganizationsindustryresidentssubmit contenteventsevents listingevents calendarabstract deadlinessubmit an eventaboutparticipation ctsnet strategic planctsnet strategic plansponsorssponsorshipsubmit content to ctsnetdisclaimerprivacy policyctsnet comment policycontact usappslog inregister an account search search form search surgeons alert this site is not optimized for internet explorer  or older please upgrade to a newer version of internet explorer or use an alternate browser such as chrome or firefox stephan toutain stephan toutain alexion pharmaceuticals inc cheshire ct   united states   6   6 fax you need to be logged in to see this email login printerfriendly organizations cardiothoracic surgery network surgery stephan toutain and mary hiter  genomeweb skip to main content rss feeds twitter linkedin log in join now business  policybusiness news research funding policy  legislation regulatory news reimbursement technologymicroarrays  multiplexing pcr informatics sequencing mass spec sample prep gene silencinggene editing researchgenetic research gene expression research epigenetics research proteomics  protein research cell biology research diagnosticsmolecular diagnostics companion diagnostics biomarker discovery  validation drug discovery  development clinical sequencing clinical proteomics disease areascancer infectious disease cardiovascular disease neurological  psychological disease metabolic disease autoimmune disease inherited disease reproductive health applied markets resourceswebinars white papers the scan career blog job listings new products people in the news conferences  events main menu enter your keywords home » resources » people in the news » stephan toutain and mary hiter stephan toutain and mary hiter aug  6 interleukin genetics has appointed stephan toutain as chief commercial officer and mary hiter as director of marketing toutain joins interleukin genetics following three years as a marketing and market access consultant to the biopharmaceutical industry he previously headed global commercial development for sarepta therapeutics and served as general manager for alexion in europe hiter joins interleukin genetics from abbott point of care where she served for eight years as director of marketing prior to abbott she held various marketing and product management roles with cybertronics now livanova watson pharmaceuticals and knoll pharmaceuticals more like this jul   cynthia bens cynthia bens will join the personalized medicine coalition as vice president of public policy on august  bens comes to pmc after more than a decade with the alliance for aging research where she helped advocate for policies including the st century cures act the prescription drug user fee act and fda’s patientfocused drug development initiative prior to that she spent four years at the bipartisan government affairs firm the loeffler group and also worked as a staff assistant on capitol hill jul 6  rohit khanna waters said in a filing with the us securities and exchange commission this week that rohit khanna has resigned from his position as svp applied technology effective july   khanna will continue to serve as an svp of the company and as a member of the firms executive committee until his retirement on dec    jul 6  scott howell tenet diagnostics has appointed scott howell its cmo he was most recently executive medical director at heritage provider network he also continues to practice at kaiser permanente los angeles medical center in the addiction medicine department he was previously national senior medical director and chief medical officer network and population health optim insight regional cmo northeast region of americhoice and national medical director of managed care for aids healthcare foundation  jul 6  gene defelice alexandra snyder adaptive biotechnologies has appointed gene defelice to senior vice president and general counsel and alexandra snyder to translational medicine lead for adaptive researchdefelice has served as general counsel for several public healthcare and technology companies including as primary counsel at roche diagnostics he will join adaptives executive team to implement a legal infrastructure for clinical applications of nextgeneration sequencing technologiessnyder has joined adaptive from memorial sloan kettering cancer research center where she specialized in tumor immunogenomics and response to checkpoint blockade immunotherapy   jul   kieran murphy stephen kanovsky kieran murphy has resigned from the board of neogenomics following his appointment as president and ceo of ge healthcare neogenomics said in a document filed with the us securities and exchange commission that murphy resigned due to the time demands of his new job and added that it has appointed stephen kanovsky to fill murphys position on the board he is general counsel of ge unit global innovation of ge healthcare jul   thomas loewald thomas loewald senior vice president and chief commercial officer at thermo fisher scientific since early 6 will resign from the company effective september  he joined the firms explosives detection business in  and held various positions over the years including senior vice president and president of laboratory products prior to that he was vice president of sales and marketing for tyco international jul   mark stevenson mark stevenson has been promoted to executive vice president and chief operation officer of thermo fisher scientific effective august  in his new role he will oversee operations of the companys laboratory products and analytical instruments businesses in addition to the life sciences solutions business since  when thermo fisher acquired life technologies stevenson has been executive vice president and president of life sciences solutions prior to that he was president and chief operating officer of life technologies and before that he was president and coo of applied biosystems jul   hans bishop hans bishop has been elected to agilents board of directors bishop is cofounder president and ceo of juno therapeutics a seattlebased biopharmaceutical company he has also held a range of executive positions in the pharmaceutical industry including as coo at dendreon president of specialty medicine at bayer healthcare and global commercial head for chiron jul   daniel sikkema quanterix has appointed daniel sikkema as vice president of acclerator services for the companys new simoa accelerator lab a dedicated environment for biomarker research custom assay development and clinical sample testing sikkema will work to expand the reach of quanterixs accelerator lab services in neurology oncology immunooncology infectious disease inflammatory diseases and other therapeutic areas he has previously worked at frontage lab bristolmyers squibb wyeth merck sanofi pasteur and glaxosmithkline jul   stephen pereira stephen pereira has been appointed to immunovias scientific advisory board pereira is a professor of hepatology and gastroenterology at university college london and is an honorary consultant in pancreaticobiliary medicine at ucl hospitals and the royal free hospital  jul   daniel macarthur the american society of human genetics has named daniel macarthur as the first recipient of its early career award he is an assistant professor in the analytic and translational genetics unit at massachusetts general hospital and harvard medical school and the codirector of the medical and population genetics program at the broad institute the new award which comes with  in prize money recognizes contributions of genetics and genomics scientists in the first  years of their careers as independent investigators macarthur and his colleagues developed the exome aggregation consortium exac database and website and its successor the genome aggregation database gnomad he also published many scientific articles on identifying genes associated with rare diseases in particular muscular disorders jul   mary thistle enterome has appointed mary thistle to its board of directors as a nonexecutive director thistle currently serves as chief operating officer at dimension therapeutics and has also served as senior vp of business development at cubist pharmaceuticals prior to joining dimension in  thistle held leadership positions at viacell in addition to developing therapeutic products for rare and metabolic liver diseases enterome also develops diagnostics to support therapies in microbiomerelated diseases such as inflammatory bowel disease and cancer jul   arthur beaudet the american society of human genetics has named arthur beaudet the recipient of this years victor a mckusick leadership award the award recognizes individuals whose professional achievements have fostered and enriched the development of human genetics as well as its assimilation into the broader context of science medicine and health beaudet who will receive the award along with a  prize at the ashg annual meeting in october is the henry and emma mayer professor in the department of molecular and human genetics and the department of pediatrics at baylor college of medicine he is a member of the national academy of medicine and the national academy of sciences and has received several other awards for his work beaudet has published more than  articles in the scientific literature  jul   kári stefánsson the american society of human genetics has named kári stefánsson the winner of this years william allan award a prize established in 6 that recognizes a scientist for substantial and farreaching scientific contributions to human genetics stefánsson is the founder of icelands decode genetics which has conducted a largescale population genetics research project in iceland he has published more than  articles in the scientific literature and has received several awards for his work including the european society of human genetics award in  jul   matthias raquet oneservice a swiss company offering complete managed service solutions consulting and learning for the life science diagnostics and medical device industries has appointed matthias raquet as ceo raquet joins oneservice from qiagen where he has worked since  most recently as vice president and head of global service solutions and global customer management prior to qiagen he worked in various management roles at amersham pharmacia breaking news new england biolabs ttp partner to provide mdx development services people in the news thomas loewald gene defelice alexandra snyder and more in brief this week perkinelmer bd eurofins scientific and more oneome inks deal to offer pgx test in canada panel sequencing leads to pathogenic mutations in autoinflammatory cases genetic technologies reports ak in cash receipts for q the scan concentration of rare disease polygamy amplified a rare genetic disease in area near arizonautah border bbc future reports unexpected findings genetic ancestry testing led one woman to learn that her father and another baby boy had been switched at birth the washington post reports make it a bit fuzzy simple deidentification methods can protect information in a database from attackers a new study suggests this week in science in science this week approach to visualize chromatin structure in nuclei and more sponsorships about us advertise contact jobs subscribe privacy policy  copyright   genomeweb llc  all rights reserved interleukin genetics – interleukin genetics strengthens commercial leadership with key appointments interleukin genetics strengthens commercial leadership with key appointments interleukin genetics strengthens commercial leadership with key appointmentsstephan toutain appointed chief commercial officer and mary hiter appointed director of marketingwaltham mass – august  6 – interleukin genetics inc otcqb iliu a life science company focused on the genetics of chronic inflammation today announced the appointment of two senior leaders to enhance its commercial team and capabilities stephan toutain will join interleukin as chief commercial officer and mary hiter will become director of marketing both newly created roles at the company mr toutain and ms hiter will join interleukin later this month“these appointments are an important step in our strategy to drive the market adoption of our periopredict® genetic risk test and patient engagement platform stephan is a seasoned business leader and an experienced sales and marketing executive who will take the lead in accelerating our commercial strategy” said mark carbeau chief executive officer of interleukin genetics “mary brings significant product launch experience and a strong network to the marketing role we are getting positive feedback on our turnkey solution from prospective customers which validates our commercial strategy with stephan’s and mary’s collective expertise in creating market access and launching new products in innovative categories we believe they have the essential track record to spearhead our commercial activities”“interleukin is a creative company built on a solid scientific foundation with an innovative product and service platform that has the potential to transform the management of several chronic diseases” said stephan toutain newly appointed chief commercial officer “interleukin biology is an area of great interest today and there is increasing enthusiasm around periopredict this is an exciting time to join the company and i look forward to driving our growth”mr toutain brings more than  years of commercial development market access and sales and marketing leadership with particular expertise in ultraorphan drug and orphan oncology markets worldwide he joins interleukin genetics following three years as a successful consultant to the biopharmaceutical industry addressing marketing strategy and access challenges previously he headed global commercial development for sarepta therapeutics cambridge ma and served as general manager for alexion in europe prior to these roles mr toutain held various commercial marketing and product management positions with alexion pharmaceuticals celgene corporation and johnson  johnson he received a master of business administration from university of north carolina and a master of engineering in biotechnology from university of nancy ii in francems hiter will contribute nearly  years experience as a healthcare marketing executive and has successfully launched multiple diagnostic medical device and specialty pharmaceutical products  she joins interleukin genetics from abbott point of care where she served for eight years as director of marketing  prior to abbott ms hiter held various marketing and product management roles with cyberonics inc now livanova watson pharmaceuticals and knoll pharmaceuticals ltd  she received a bachelor of science in biology from chatham college pittsburghabout periopredictperiopredict is an innovative easytouse genetic test that identifies individuals with an increased risk for severe and progressive periodontitis due to a lifelong genetic predisposition to overproduce interleukin il a key mediator of inflammation such individuals may benefit from enhanced dental care to prevent or treat periodontitis and thereby lower their systemic inflammatory burden targeted management of systemic inflammation has been shown to help manage several chronic diseases including type  diabetes and coronary artery disease the periopredict test is made available to employees in covered health plans under the supervision of a licensed dentist or physician and the results provide important information to dental professionals for assessing prevention and treatment options for their patients the periopredict test is run solely in interleukin’s cliacertified lab in waltham ma for more information please visit wwwperiopredictcomabout interleukin geneticsinterleukin genetics inc otcqb iliu develops and markets proprietary genetic tests for chronic inflammatory diseases and healthrelated conditions with significant expertise in metabolism and inflammation our tests provide information that is not otherwise available to empower individuals and their healthcare providers to manage their health and wellness through geneticsbased insights and actionable guidance interleukin genetics leverages its research intellectual property and genetic panel development expertise in inflammation and metabolism to identify individuals whose risk for certain chronic disease may be increased due to variants in one or more genes which can enable a more targeted approach to the individual’s healthcare the company markets its tests through healthcare professionals partnerships with health and wellness companies and other distribution channels interleukin genetics’ lead products include its proprietary periopredict® genetic test that identifies individuals at risk for severe periodontal disease and a lifelong predisposition to overproduce inflammation and its inherent health® line of genetic tests interleukin genetics is headquartered in waltham ma and operates an onsite stateoftheart dna testing laboratory certified under the clinical laboratory improvement amendments clia for more information please visit wwwilgeneticscomforwardlooking statementscertain statements contained herein are “forwardlooking” statements including but not limited to statements regarding accelerating commercial strategy and driving growth because such statements include risks and uncertainties actual results may differ materially from those expressed or implied by such forwardlooking statements  factors that could cause actual results to differ materially from those expressed or implied by such forwardlooking statements include but are not limited to those risks and uncertainties described in interleukin’s annual report on form k for the year ended december   and other filings with the securities and exchange commission  interleukin disclaims any obligation or intention to update these forwardlooking statementsinvestor contacthans vitzthum lifesci advisors llc  6 hanslifesciadvisorscommedia contact jennifer moritz zer to ive for interleukin genetics  6 jmoritztocomshare this